In This Section

AACR Grantees Share their Findings 

We are extremely proud of our past and present grantees who presented and published their findings this past year. Their accomplishments have been made possible through the support of the AACR and its funding partners. 


Targeted nanoparticles for the treatment of pancreatic cancer 

Overcoming the blood brain barrier with tumor treating fields 


Epigenetic age and lung cancer risk 

Advancing smoking cessation and physical activity among Latinos 

A new therapeutic strategy for p53-inactivated triple negative breast cancer 

Targeting chromosomal instability tolerance in metastatic prostate cancer 

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer Veronica Rodriguez-Bravo, PhD, 2018 Friends of the AACR Foundation Early Career Investigator Award 


Host factors that influence papilloma virus-induced disease 

Molecular basis of cancer health disparities in head and neck cancer 


AACR Annual Meeting  

Role of the glycerol-3-phosphate shuttle in cancer 

Oral health and lung cancer risk 

Molecular signatures of response to neoadjuvant immune checkpoint blockade in bladder cancer 

Dr. Daniel Arango, recipient of the 2022 AACR Career Development Award to Further Diversity, Equity, and Inclusion in Cancer Research, discusses his work with fellow AACR grant recipient, Dr. Francesca Citron (2022 AACR-AstraZeneca Stimulating Therapeutic Advances through Research Training (START) Grant) at the 2023 AACR Annual Meeting Grantee Poster Reception.


The role of adjuvant endocrine therapy in racial disparities in survival 

Kimberley Lee, MD, MHS, 2021 Breast Cancer Research Foundation-AACR Career Development Award to Promote Diversity and Inclusion 

Phase I clinical trial on immunotherapy combination in uveal melanoma 


Remodeling of the tumor microenvironment in Ewing sarcoma 


Molecular insights on response to tumor treating fields in glioblastoma 

Novel assay to elucidate glucosome assembly 


RNA splicing in pancreatic cancer 

“RNA switches” in pancreatic cancer: Expression, splicing and RNA-based therapeutics Luisa Escobar-Hoyos, 2021 AACR Career Development Award to Further Diversity, Equity, and Inclusion in Pancreatic Cancer Research 


HRD effect on T-cell exhaustion in ovarian cancer 

T-cell exhaustion is an independent predictive biomarker of clinical outcome in high grade serous ovarian cancer regardless of homologous recombination deficiency status Anna Salvioni, PhD, 2023 AACR-AstraZeneca Ovarian Cancer Research Fellowship 


Interrogating the impact of tumor treating fields